SCHEMBL548085

SCHEMBL548085

CC(S)S.[Bi]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL330158 0.93
Water SCHEMBL8933153 0.86
Arsenic SCHEMBL29055920 0.86
SCHEMBL30278868 0.86
SCHEMBL16534416 0.86
Hydrogen Sulfide SCHEMBL9331422 0.86
SCHEMBL30061369 0.86
SCHEMBL18938858 0.80
SCHEMBL5250 0.77
Methylsulfanylmethane SCHEMBL28924791 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160058772-A1 BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES MICROBION CORPORATION 2016-03-03 US claimed
US-20110092589-A1 Treatment of Inflammatory Conditions and Diseases with Metal-Thiols THE CHARLOTTE-MECKLENBURG HOSPOTAL AUTHORITY (US) 2011-04-21 US claimed
EP-2265265-A2 TREATMENT OF INFLAMMATORY CONDITIONS AND DISEASES WITH METAL-THIOLS The Charlotte-Mecklenburg Hospital Authority (US) 2010-12-29 EP claimed
WO-2009154819-A2 TREATMENT OF INFLAMMATORY CONDITIONS AND DISEASES WITH METAL-THIOLS THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (US) 2009-12-23 WO claimed
US-6380248-B1 THERAPY AND PROPHYLAXIS OF SEPSIS AND SEPTIC SHOCK ADMINISTERING A GROUP V METAL CHELATED BY A COMPLEXING AGENT SUCH AS THIOL COMPOUNDS IN THE FORM OF A METAL:COMPLEXING AGENT WINTHROP UNIVERSITY HOSPITAL 2002-04-30 US claimed
US-20260137086-A1 METHODS TO REDUCE CONTAMINATION, BIOFILM AND FOULING FROM WATER SYSTEMS, SURFACES, AND PRODUCTS AEQUOR INC. (US) 2026-05-21 US disclosed
US-12186283-B2 Bismuth-thiol compositions and methods of use MICROBION CORPORATION (US) 2025-01-07 US disclosed
WO-2023250347-A1 METHODS TO REDUCE CONTAMINATION, BIOFILM, AND FOULING FROM WATER SYSTEMS AND SURFACES AEQUOR, INC. (US) 2023-12-28 WO disclosed
US-20230165808-A1 BISMUTH-THIOL COMPOSITIONS AND METHODS OF USE MICROBION CORPORATION 2023-06-01 US disclosed
US-20230124862-A1 BISMUTH THIOL COMPOUNDS AND COMPOSITIONS AND METHODS OF TREATING MICROBIAL CO-INFECTIONS MICROBION CORPORATION 2023-04-20 US disclosed
US-20220322671-A1 METHODS TO REDUCE CONTAMINATION, BIOFILM AND FOULING FROM WATER SYSTEMS, SURFACES, AND PRODUCTS AEQUOR, INC. (US) 2022-10-13 US disclosed
US-11464749-B2 Bismuth-thiol compositions and methods of use MICROBION CORPORATION (US) 2022-10-11 US disclosed
WO-2002083926-A2 METHODS OF DIAGNOSING AND TREATING SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) AND SIBO-RELATED CONDITIONS CEDARS-SINAI MEDICAL CENTER (US) 2002-10-24 WO disclosed
US-6380248-B1 THERAPY AND PROPHYLAXIS OF SEPSIS AND SEPTIC SHOCK ADMINISTERING A GROUP V METAL CHELATED BY A COMPLEXING AGENT SUCH AS THIOL COMPOUNDS IN THE FORM OF A METAL:COMPLEXING AGENT WINTHROP UNIVERSITY HOSPITAL 2002-04-30 US disclosed
US-20020039599-A1 Calibration; administering antiseptic compound NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-04-04 US disclosed
US-6248371-B1 TUBERCULOSIS WINTHROP UNIVERSITY HOSPITAL 2001-06-19 US disclosed
EP-1064004-A1 METAL/THIOL BIOCIDES Winthrop-University Hospital (US) 2001-01-03 EP disclosed
US-6086921-A Metal/thiol biocides WINTROP-UNIVERSITY HOSPITAL (US) 2000-07-11 US disclosed
WO-1999039707-A1 METAL-THIOLS AS IMMUNOMODULATING AGENTS WINTHROP-UNIVERSITY HOSPITAL (US) 1999-08-12 WO disclosed
WO-1999021568-A1 METAL/THIOL BIOCIDES WINTHROP-UNIVERSITY HOSPITAL (US) 1999-05-06 WO disclosed